PubMed中文版
| PubMed ID | 36430432 |
|---|---|
| 发表日期 | 2022 Nov 12 |
| 作者 | Passeri E Elkhoury K Morsink M Broersen K Linder M Tamayol A Malaplate C Yen FT Arab-Tehrany E |
| 文献标题 | Alzheimer's Disease: Treatment Strategies and Their Limitations. |
| 原始出处 | International journal of molecular sciences |
| 影响因子 | 4.9 期刊引文指标 0.71 |
| PubMed ID | 39293530 |
|---|---|
| 发表日期 | 2024 Nov |
| 作者 | Kale M Wankhede N Pawar R Ballal S Kumawat R Goswami M Khalid M Taksande B Upaganlawar A Umekar M Kopalli SR Koppula S |
| 文献标题 | AI-driven innovations in Alzheimer's disease: Integrating early diagnosis, personalized treatment, and prognostic modelling. |
| 原始出处 | Ageing research reviews |
| 影响因子 | 12.4 期刊引文指标 1.68 |
| PubMed ID | 30689575 |
|---|---|
| 发表日期 | 2019 |
| 作者 | Cummings JL Tong G Ballard C |
| 文献标题 | Treatment Combinations for Alzheimer's Disease: Current and Future Pharmacotherapy Options. |
| 原始出处 | Journal of Alzheimer's disease : JAD |
| 影响因子 | 3.1 期刊引文指标 0.85 |
| PubMed ID | 41448139 |
|---|---|
| 发表日期 | 2025 Dec 24 |
| 作者 | Courade JP Zetterberg H Höglinger GU Dewachter I |
| 文献标题 | The evolving landscape of Alzheimer's disease therapy: From Aβ to tau. |
| 原始出处 | Cell |
| 影响因子 | 42.5 期刊引文指标 7.99 |
| PubMed ID | 38853102 |
|---|---|
| 发表日期 | 2024 Jul |
| 作者 | Turgutalp B Kizil C |
| 文献标题 | Multi-target drugs for Alzheimer's disease. |
| 原始出处 | Trends in pharmacological sciences |
| 影响因子 | 19.9 期刊引文指标 2.2 |
| PubMed ID | 40473116 |
|---|---|
| 发表日期 | 2025 Jul |
| 作者 | Su CH Chang YT Tseng HS Kuo CY Chen JH Chien PY Chang YJ Hung CC |
| 文献标题 | Comparisons of efficacy and safety of immunotherapies for Alzheimer's disease treatment: A network meta-analysis of randomised controlled trials. |
| 原始出处 | Clinical medicine (London, England) |
| 影响因子 | 3.9 期刊引文指标 0.86 |
| PubMed ID | 31127076 |
|---|---|
| 发表日期 | 2019 May 24 |
| 作者 | Fonte C Smania N Pedrinolla A Munari D Gandolfi M Picelli A Varalta V Benetti MV Brugnera A Federico A Muti E Tamburin S Schena F Venturelli M |
| 文献标题 | Comparison between physical and cognitive treatment in patients with MCI and Alzheimer's disease. |
| 原始出处 | Aging |
| 影响因子 |
| PubMed ID | 38685540 |
|---|---|
| 发表日期 | 2024 Jun |
| 作者 | Lee HJ Choi HJ Jeong YJ Na YH Hong JT Han JM Hoe HS Lim KH |
| 文献标题 | Developing theragnostics for Alzheimer's disease: Insights from cancer treatment. |
| 原始出处 | International journal of biological macromolecules |
| 影响因子 | 8.5 期刊引文指标 1.52 |
| PubMed ID | 24121964 |
|---|---|
| 发表日期 | 2014 |
| 作者 | Chancellor B Duncan A Chatterjee A |
| 文献标题 | Art therapy for Alzheimer's disease and other dementias. |
| 原始出处 | Journal of Alzheimer's disease : JAD |
| 影响因子 | 3.1 期刊引文指标 0.85 |
| PubMed ID | 30475773 |
|---|---|
| 发表日期 | 2019 |
| 作者 | Watt AD Jenkins NL McColl G Collins S Desmond PM |
| 文献标题 | Ethical Issues in the Treatment of Late-Stage Alzheimer's Disease. |
| 原始出处 | Journal of Alzheimer's disease : JAD |
| 影响因子 | 3.1 期刊引文指标 0.85 |
| PubMed ID | 38940847 |
|---|---|
| 发表日期 | 2024 Nov |
| 作者 | Soni AG Verma A Joshi R Shah K Soni D Kaur CD Saraf S Chauhan NS |
| 文献标题 | Phytoactive drugs used in the treatment of Alzheimer's disease and dementia. |
| 原始出处 | Naunyn-Schmiedeberg's archives of pharmacology |
| 影响因子 | 3.1 期刊引文指标 0.78 |
| PubMed ID | 37495380 |
|---|---|
| 发表日期 | 2023 Nov 7 |
| 作者 | Ramanan VK Armstrong MJ Choudhury P Coerver KA Hamilton RH Klein BC Wolk DA Wessels SR Jones LK Jr AAN Quality Committee |
| 文献标题 | Antiamyloid Monoclonal Antibody Therapy for Alzheimer Disease: Emerging Issues in Neurology. |
| 原始出处 | Neurology |
| 影响因子 | 8.5 期刊引文指标 2.54 |
| PubMed ID | 39274904 |
|---|---|
| 发表日期 | 2024 Aug 27 |
| 作者 | Daraban BS Popa AS Stan MS |
| 文献标题 | Latest Perspectives on Alzheimer's Disease Treatment: The Role of Blood-Brain Barrier and Antioxidant-Based Drug Delivery Systems. |
| 原始出处 | Molecules (Basel, Switzerland) |
| 影响因子 | 4.6 期刊引文指标 0.72 |
| PubMed ID | 39422965 |
|---|---|
| 发表日期 | 2024 |
| 作者 | Sayfullaeva J McLoughlin J Kwakowsky A |
| 文献标题 | Hormone Replacement Therapy and Alzheimer's Disease: Current State of Knowledge and Implications for Clinical Use. |
| 原始出处 | Journal of Alzheimer's disease : JAD |
| 影响因子 | 3.1 期刊引文指标 0.85 |
| PubMed ID | 38945936 |
|---|---|
| 发表日期 | 2024 |
| 作者 | Suzuki N Hatta T Ito M Kusakabe KI |
| 文献标题 | Anti-amyloid-β Antibodies and Anti-tau Therapies for Alzheimer's Disease: Recent Advances and Perspectives. |
| 原始出处 | Chemical & pharmaceutical bulletin |
| 影响因子 | 1.3 期刊引文指标 0.33 |
| PubMed ID | 38018199 |
|---|---|
| 发表日期 | 2023 |
| 作者 | Rajput S Malviya R Bahadur S Puri D |
| 文献标题 | Recent Updates on the Development of Therapeutics for the Targeted Treatment of Alzheimer's Disease. |
| 原始出处 | Current pharmaceutical design |
| 影响因子 | 2.8 期刊引文指标 0.49 |
| PubMed ID | 32284421 |
|---|---|
| 发表日期 | 2020 Apr 28 |
| 作者 | Rezai AR Ranjan M D'Haese PF Haut MW Carpenter J Najib U Mehta RI Chazen JL Zibly Z Yates JR Hodder SL Kaplitt M |
| 文献标题 | Noninvasive hippocampal blood-brain barrier opening in Alzheimer's disease with focused ultrasound. |
| 原始出处 | Proceedings of the National Academy of Sciences of the United States of America |
| 影响因子 | 9.1 期刊引文指标 2.3 |
| PubMed ID | 40691719 |
|---|---|
| 发表日期 | 2025 Sep |
| 作者 | Rafii MS Aisen PS |
| 文献标题 | Amyloid-lowering immunotherapies for Alzheimer disease: current status and future directions. |
| 原始出处 | Nature reviews. Neurology |
| 影响因子 | 33.1 期刊引文指标 5.7 |
| PubMed ID | 10947490 |
|---|---|
| 发表日期 | 2000 Apr |
| 作者 | Hauber AB Gnanasakthy A Snyder EH Bala MV Richter A Mauskopf JA |
| 文献标题 | Potential savings in the cost of caring for Alzheimer's disease. Treatment with rivastigmine. |
| 原始出处 | PharmacoEconomics |
| 影响因子 | 4.6 期刊引文指标 1.32 |
| PubMed ID | 31594236 |
|---|---|
| 发表日期 | 2019 |
| 作者 | Morsy A Trippier PC |
| 文献标题 | Current and Emerging Pharmacological Targets for the Treatment of Alzheimer's Disease. |
| 原始出处 | Journal of Alzheimer's disease : JAD |
| 影响因子 | 3.1 期刊引文指标 0.85 |